UK markets closed

Achiko AG (ACHKF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.24140.0000 (0.00%)
As of 10:31AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close0.2414
Open0.2414
BidN/A x N/A
AskN/A x N/A
Day's range0.2414 - 0.2414
52-week range0.2414 - 0.4123
Volume21,544
Avg. volume0
Market cap27.955M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-0.1370
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Achiko’s Covid-19 DNA Aptamer-Based Rapid Testing Platform Update

    Pilot program in Indonesia is on track with positive results and support for Achiko’s proprietary, low-cost rapid Covid-19 diagnostic test, AptameX, alongside its sister digital passporting service Teman Sehat (“Health Buddy”)Approval for the second-generation AptameX test kit expected in December from Indonesia’s Ministry of HealthCE Mark registration is close to finalization with filing early next yearInitial production of first-generation AptameX test kit is underway in Indonesia to fulfil pr

  • Globe Newswire

    Achiko Initiates Development of Dengue Diagnostic Test

    Achiko to develop dengue fever diagnostic test by applying its DNA aptamer technology platform. This is another promising application of the technology that Achiko is already successfully using to diagnose Covid-19.The dengue virus infects about 400 million people every year and is endemic to where 3.6 billion (40%) of the world’s population live.Achiko is developing a range of diagnostic tests for other pathogenic diseases applying DNA aptamer technology. ZURICH, Switzerland, Nov. 05, 2021 (GLO

  • Globe Newswire

    Achiko Secures Initial Sales of AptameX Covid-19 Diagnostic Test

    Achiko has received its first purchase order in Jakarta and Bali in Indonesia.The orders translate to 20,000 tests - while modest in size, the order is expected to pave the way to rapid adoption by other locations and countries.After consolidating the results of the first sales, the pilot project, and the data from the first production, the platform will be quickly scaled and supplemented with additional products.Following the receipt of the CE marking, the expansion into further countries will